Sabra Healthcare REIT, Inc. (SBRA) Position Lifted by BNP Paribas Arbitrage SA

BNP Paribas Arbitrage SA raised its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 208.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,030 shares of the real estate investment trust’s stock after purchasing an additional 91,221 shares during the quarter. BNP Paribas Arbitrage SA owned about 0.08% of Sabra Healthcare REIT worth $2,963,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Global X MANAGEMENT CO LLC lifted its holdings in Sabra Healthcare REIT by 127.6% during the third quarter. Global X MANAGEMENT CO LLC now owns 800,918 shares of the real estate investment trust’s stock valued at $17,572,000 after purchasing an additional 449,030 shares in the last quarter. Essex Financial Services Inc. lifted its stake in shares of Sabra Healthcare REIT by 25.3% in the third quarter. Essex Financial Services Inc. now owns 16,327 shares of the real estate investment trust’s stock worth $358,000 after buying an additional 3,299 shares in the last quarter. Advantus Capital Management Inc lifted its stake in shares of Sabra Healthcare REIT by 98.1% in the third quarter. Advantus Capital Management Inc now owns 236,281 shares of the real estate investment trust’s stock worth $5,184,000 after buying an additional 117,010 shares in the last quarter. Swiss National Bank lifted its stake in shares of Sabra Healthcare REIT by 172.9% in the third quarter. Swiss National Bank now owns 293,041 shares of the real estate investment trust’s stock worth $6,429,000 after buying an additional 185,641 shares in the last quarter. Finally, World Asset Management Inc purchased a new position in shares of Sabra Healthcare REIT in the third quarter worth about $235,000. Hedge funds and other institutional investors own 85.51% of the company’s stock.

Several equities research analysts recently issued reports on the stock. TheStreet cut shares of Sabra Healthcare REIT from a “b-” rating to a “c” rating in a research report on Friday, November 3rd. SunTrust Banks reiterated a “buy” rating and set a $25.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, November 3rd. Stifel Nicolaus reissued a “hold” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Friday, November 3rd. Zacks Investment Research downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research note on Wednesday, October 25th. Finally, Mizuho reiterated a “hold” rating and issued a $23.00 price target on shares of Sabra Healthcare REIT in a research note on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $24.40.

In related news, Director Milton J. Walters sold 4,615 shares of Sabra Healthcare REIT stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $19.18, for a total transaction of $88,515.70. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.60% of the stock is currently owned by company insiders.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) traded down $0.18 during trading on Wednesday, hitting $18.82. The stock had a trading volume of 1,219,895 shares, compared to its average volume of 1,584,088. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market cap of $3,443.45, a PE ratio of 8.47, a P/E/G ratio of 2.51 and a beta of 0.92. Sabra Healthcare REIT, Inc. has a 12 month low of $18.48 and a 12 month high of $29.10.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Tuesday, November 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 221.28%.

COPYRIGHT VIOLATION WARNING: This news story was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/12/06/bnp-paribas-arbitrage-sa-buys-91221-shares-of-sabra-healthcare-reit-inc-sbra.html.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply